Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diwei Zheng

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cell Reports|July 12, 2023
T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activityYuanbin Cui, Tingjie Yuan, Ying Wang, et al.
Journal of Hematology & Oncology|February 20, 2019
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancerJiang Lv, Ruocong Zhao, Di Wu, et al.
Leukemia|November 10, 2020
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cellsZhiwu Jiang, Rui Liao, Jiang Lv, et al.
Biomarker Research|March 25, 2022
Human induced-T-to-natural killer cells have potent anti-tumour activitiesZhiwu Jiang, Le Qin, Yuou Tang, et al.
Imeta|January 1, 2025
<i>iMeta</i> Conference 2024: Building an innovative scientific research ecosystem for microbiome and One HealthYao Wang, Huiyu Hou, Hao Luo, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cell Reports|July 12, 2023
T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activityYuanbin Cui, Tingjie Yuan, Ying Wang, et al.
Journal of Hematology & Oncology|February 20, 2019
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancerJiang Lv, Ruocong Zhao, Di Wu, et al.
Leukemia|November 10, 2020
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cellsZhiwu Jiang, Rui Liao, Jiang Lv, et al.
Biomarker Research|March 25, 2022
Human induced-T-to-natural killer cells have potent anti-tumour activitiesZhiwu Jiang, Le Qin, Yuou Tang, et al.
Imeta|January 1, 2025
<i>iMeta</i> Conference 2024: Building an innovative scientific research ecosystem for microbiome and One HealthYao Wang, Huiyu Hou, Hao Luo, et al.
Pageof 5